Onychomycosis : Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes - 22/05/16
Résumé |
Onychomycosis is the most common nail disease seen in podiatric practice. Effective long-term management remains problematic. We need to treat onychomycosis effectively to prevent its progression into a severe, debilitating, and painful condition, and to manage recurrence. With new agents now available and greater discussion on management strategies, this article reviews the appropriate evaluation of the disease, treatment options, and optimal patient outcomes.
Le texte complet de cet article est disponible en PDF.Keywords : Onychomycosis, Efinaconazole, Tavaborole, Laser, Toenail, Trichophyton rubrum, Mycosis, Tinea pedis
Plan
| Disclosures: Advisor, speaker and investigator for Valeant and Pharmaderm. |
|
| The authors acknowledge Brian Bulley, MSc, of Inergy Limited for medical writing support. Valeant Pharmaceuticals North America LLC funded Inergy’s activities pertaining to this article. |
Vol 33 - N° 3
P. 305-318 - juillet 2016 Retour au numéro
Article précédent
- Lower Extremity Skin Manifestations: A Multidisciplinary Effort
- Tracey C. Vlahovic
- Dermatologic Manifestations of the Lower Extremity : Nail Surgery
- Nathaniel J. Jellinek, Nicole F. Vélez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?